Cargando…
Prodrug Strategies for Paclitaxel
Paclitaxel is an anti-tumor agent with remarkable anti-tumor activity and wide clinical uses. However, it is also faced with various challenges especially for its poor water solubility and low selectivity for the target. To overcome these disadvantages of paclitaxel, approaches using small molecule...
Autores principales: | Meng, Ziyuan, Lv, Quanxia, Lu, Jun, Yao, Houzong, Lv, Xiaoqing, Jiang, Feng, Lu, Aiping, Zhang, Ge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881612/ https://www.ncbi.nlm.nih.gov/pubmed/27223283 http://dx.doi.org/10.3390/ijms17050796 |
Ejemplares similares
-
Molecular Mechanisms and Translational Therapies for Human Epidermal Receptor 2 Positive Breast Cancer
por: Lv, Quanxia, et al.
Publicado: (2016) -
Methods to Design and Synthesize Antibody-Drug Conjugates (ADCs)
por: Yao, Houzong, et al.
Publicado: (2016) -
Chemical Modifications of Nucleic Acid Aptamers for Therapeutic Purposes
por: Ni, Shuaijian, et al.
Publicado: (2017) -
A water-soluble nucleolin aptamer-paclitaxel conjugate for tumor-specific targeting in ovarian cancer
por: Li, Fangfei, et al.
Publicado: (2017) -
Molecular Selection, Modification and Development of Therapeutic Oligonucleotide Aptamers
por: Yu, Yuanyuan, et al.
Publicado: (2016)